338 filings
Page 8 of 17
8-K
k9ems79fu46lak8 57
1 Nov 18
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results
8:05am
8-K
oqbj aoj99qktk0
2 Aug 18
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2018 Financial Results
8:01am
8-K
pko2ldd
10 Jul 18
Pacira Reports Preliminary Net EXPAREL® Sales of $80.4 Million for Second Quarter of 2018
7:34am
8-K
4udhei kylizcfsx756
15 Jun 18
Submission of Matters to a Vote of Security Holders
4:17pm
8-K
1gypgb
3 May 18
Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results
8:05am
8-K
6hp955ix7opwp 2r
29 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
4uw chklgu6
28 Feb 18
Pacira Reports Fourth Quarter and Full Year 2017
12:00am
8-K
hnr8j ixapwl
4 Jan 18
Pacira Pharmaceuticals Reports Preliminary 2017 Revenues of $286.6 Million
12:00am
8-K
cuxmygzdb4 awc
7 Dec 17
Pacira Announces Promotions of Scott Braunstein, MD, to Chief Operating Officer and Richard Scranton, MD, to Chief Scientific Officer
12:00am
8-K
bux1phd gl7
8 Nov 17
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2017 Financial Results
12:00am
8-K
au0v9hvc1f sx
25 Oct 17
Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement
12:00am
CT ORDER
i539z saialjy
12 Sep 17
Confidential treatment order
12:00am
8-K
g0nb19yp1335w20r2
2 Aug 17
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial Results
12:00am
8-K
0i6w477mf22640b gvdq
29 Jun 17
Cost Associated with Exit or Disposal Activities
12:00am